NAROPIN (APP Pharmaceuticals, LLC)


Welcome to the PulseAid listing for the NAROPIN drug offered from APP Pharmaceuticals, LLC. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: APP Pharmaceuticals, LLC
NON-PROPRIETARY NAME: ROPIVACAINE HYDROCHLORIDE MONOHYDRATE
SUBSTANCE NAME: ROPIVACAINE HYDROCHLORIDE MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE]
ROUTE: EPIDURAL; INFILTRATION; PERINEURAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-08-04
END MARKETING DATE: 0000-00-00


NAROPIN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNAROPIN from APP Pharmaceuticals, LLC
LABELER NAME: APP Pharmaceuticals, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/mL)
START MARKETING DATE: 2009-08-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-286_cb8b926d-cf66-bc7e-c940-e820fd4e877c
PRODUCT NDC: 63323-286
APPLICATION NUMBER: NDA020533

Other ROPIVACAINE HYDROCHLORIDE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
APP Pharmaceuticals, LLCNAROPIN